Gene- and subtype-dependent prognostic impact of ras pathway mutations in acute myeloid leukemia: a cohort study of 2,500 patients - Top-Institutions - MDSpire

Gene- and subtype-dependent prognostic impact of ras pathway mutations in acute myeloid leukemia: a cohort study of 2,500 patients

  • By

  • Heng Shen

  • Yan Hui

  • Yuntao Liu

  • Shouyun Li

  • Dong Lin

  • Qiuyun Fang

  • Ying Wang

  • Benfa Gong

  • Chunlin Zhou

  • Kaiqi Liu

  • Guangji Zhang

  • Xiaoyuan Gong

  • Shaowei Qiu

  • Bingcheng Liu

  • Yingchang Mi

  • Yan Li

  • Jianxiang Wang

  • Hui Wei

  • May 27, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Institute of Hematology and Blood Diseases Hospital of the Chinese Academy of Medical Sciences
    Institute of Hematology and Blood Diseases Hospital of the Chinese Academy of Medical Sciences

    Beijing, Beijing

    Key Differentiators

    • Hematology

  • #2

    National Taiwan University Hospital
    National Taiwan University Hospital

    Taipei, Taiwan

    Key Differentiators

    • Hematology

  • #3

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Hematology

  • #4

    Beat AML Clinical Trial
    Beat AML Clinical Trial

    N/A, N/A

    Key Differentiators

    • Hematology

Original Source(s)

Gene- and subtype-dependent prognostic impact of ras pathway mutations in acute myeloid leukemia: a cohort study of 2,500 patients

  • by Heng Shen, Yan Hui, Yuntao Liu, Shouyun Li, Dong Lin, Qiuyun Fang, Ying Wang, Benfa Gong, Chunlin Zhou, Kaiqi Liu, Guangji Zhang, Xiaoyuan Gong, Shaowei Qiu, Bingcheng Liu, Yingchang Mi, Yan Li, Jianxiang Wang, Hui Wei

  • May 27, 2026

Related Content

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort

FOXA2 in cancer: from fundamental biology to clinical translation

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry